Bispecific antibody targeting GPRC5D receptor showed an overall response rate of more than 70 percent with durable responses, including in patients previously treated with a bispecific antibody or CAR-T cell therapy HORSHAM, Pa., Aug. 10, 2023 /PRNewswire/ — The Janssen Pharmaceutical…

NEW YORK, Aug. 10, 2023 /PRNewswire/ — The Fraud Detection and Prevention Market is estimated to grow by USD 47,399.03 million during 2022-2027, growing at a CAGR of 20.22%. North America will contribute 39% to the growth of the global market during the forecast period. There are several…

OAKVILLE, ON, Aug. 10, 2023 /PRNewswire/ – Algonquin Power & Utilities Corp. (TSX: AQN) (NYSE: AQN) (“AQN” or the “Company”) today announced that it will pursue a sale of the Renewable Energy Group. “Over the past few months, the AQN Board of Directors, in conjunction with our independent…

OAKVILLE, ON, Aug. 10, 2023 /PRNewswire/ – Algonquin Power & Utilities Corp. (“AQN”) (TSX: AQN) (TSX: AQN.PR.A) (TSX: AQN.PR.D) (NYSE: AQN) announced today that its board of directors has approved and declared the following common and preferred share dividends: US$0.1085 per common share,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.